As of February 2026 Progenics Pharmaceuticals has a market cap of A$0.50 Billion. This makes Progenics Pharmaceuticals the world's 7742th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.